Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from DISA ( (SG:532) ).
DISA Limited’s subsidiary, Digital Life Line Pte. Ltd., has signed a licensing agreement with National University Hospital and National University of Singapore to commercialize MIDAS, a portable cataract diagnostic device. This initiative addresses the growing need for accessible cataract screening, facilitating early intervention and reducing non-urgent specialist referrals by utilizing AI-enabled technology in primary care settings, thereby enhancing community-level ophthalmic care.
More about DISA
DISA Limited is a company incorporated in Singapore, focusing on digital safety solutions through its subsidiary DiSa Digital Safety Pte. Ltd. The company is involved in providing innovative products that address safety and health needs.
Current Market Cap: S$10.51M
For a thorough assessment of 532 stock, go to TipRanks’ Stock Analysis page.